Bupropion hydrochloride produces conditioned hyperactivity in rats

Area of Science:

• Neuroscience
• Behavioral Pharmacology

Background:

• Bupropion, marketed as Wellbutrin and Zyban, is an antidepressant and smoking cessation aid.
• Its exact neurological mechanisms are not fully understood, but it exhibits similarities to psychomotor stimulants.

Purpose of the Study:

• To investigate the psychomotor stimulant effects of bupropion.
• To determine if repeated bupropion administration in a specific environment leads to conditioned hyperactivity.

Main Methods:

• Rats received daily bupropion injections (2.5-30 mg/kg) paired with placement in locomotor chambers.
• Locomotor activity was measured acutely and after repeated administration.
• Conditioned hyperactivity was assessed in a drug-free session following conditioning.
• Novelty reactivity was measured to predict bupropion's locomotor effects.

Main Results:

• Bupropion (10-30 mg/kg) caused acute locomotor hyperactivity compared to controls.
• No progressive changes in activity were observed after repeated administration.
• Conditioned hyperactivity was observed at 5-30 mg/kg doses in a drug-free state.
• Novelty reactivity did not predict bupropion's locomotor effects.

Conclusions:

• Environmental cues repeatedly associated with bupropion's stimulant effects can elicit hyperactivity in its absence.
• This demonstrates conditioned hyperactivity, aligning bupropion's behavioral profile with other psychomotor stimulants.
• Reactivity to novelty does not appear to predict bupropion's locomotor stimulant or conditioned effects.